BOC Q4 2025 Earnings Deep Loss Misses Estimate Despite Stock Rebound CDLX Q1 2026 Earnings Strong EPS Beat Driven by Cost Discipline Revenue Remains Under Wraps CLDX Q1 2026 Earnings Clinicalstage biotech reports widerthanexpected loss as pipeline investment continues VFF Q1 2026 Earnings EPS Misses Estimates Amid Lack of Revenue Disclosure IMXI Q1 2026 Earnings Significant EPS Miss Highlights Operational Challenges WSM Q1 2026 Earnings EPS Surprises with 575 Beat Stock Rises